Leonardo M. Fabbri
University of Ferrara
579 Papers
7.1K Citations
Leonardo M. Fabbri is an academic researcher from University of Ferrara. The author has contributed to research in topics: COPD & Medicine. The author has an hindex of 109, co-authored 566 publications. Previous affiliations of Leonardo M. Fabbri include Imperial College London & University of California, San Francisco.
Chat about Author
Papers
•Journal Article
Toluene diisocyanate-induced asthma without airway hyperresponsiveness.
TL;DR: These cases provide evidence that asthma can be induced by toluene diisocyanate in the absence of airway hyperresponsiveness and demonstrate that an isolated negative methacholine inhalation test cannot be used to exclude sensitization to TDI.
45
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
C. LaForce,Michael Alexander,R. Deckelmann,Leonardo M. Fabbri,Z. Aisanov,Ray Cameron,Roger Owen,Mark Higgins +7 more
TL;DR: Indacaterol is a novel, once‐daily β2‐agonist in development for the treatment of asthma and chronic obstructive pulmonary disease and studies were required to determine optimal dose(s) for continuing investigation.
45
Insights, attitudes, and perceptions about asthma and its treatment : a multinational survey of patients from Europe and Canada
Joaquín Sastre,Leonardo M. Fabbri,David Price,Hans Ulrich Wahn,Jean Bousquet,James E. Fish,Kevin R. Murphy,Malcolm R. Sears +7 more
TL;DR: In 2010, many surveyed patients in Europe and Canada reported features indicating uncontrolled asthma, yet the majority believed they were well controlled, indicating that they had low expectations of long-term asthma management.
44
•Journal Article
Fatal asthma in a young patient with severe bronchial hyperresponsiveness but stable peak flow records
TL;DR: This case report suggests that severe bronchial hyperresponsiveness, even in the presence of stable peak flow records, may identify asthmatic patients at risk of sudden death.
43
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.
T. M. Tessa Marthe Kole,Elise Vanden Berghe,Monica Kraft,Judith M. Vonk,Martijn C. Nawijn,Salman Siddiqui,Kai Sun,Leonardo M. Fabbri,Klaus F. Rabe,Gabriele Nicolini,Christopher E. Brightling,Dave Singh,T. van der Molen,Sven-Erik Dahlén,Alvar Agusti,Rosa Faner,Jadwiga A. Wedzicha,Gavin C. Donaldson,Huib A. M. Kerstjens,Philipp Badorrek,Mariëlle E.A.C. Broeders,Wim Boersma,Alfredo Chetta,Alberto Cukier,Mike D'Amato,Ratko Djukanovic,Maria Pia Foschino,Cathy Gessner,Nicola A. Hanania,Raul Martin,Stefano Milleri,Ron Olivenstein,Pierluigi Paggiaro,Emilio Pizzichini,Vicente Plaza Moral,D. S. Postma,Nicola Scichilone,Robert Schilz,Antonio Spanevello,Rafael Stelmach,J. Sebastiaan Vroegop,OS Usmani,Q. Zhang,H. Ahmed,David B. Allen,Séverine Ballereau,Manohara Batuwitage,A. J. Bedding,Annelie F. Behndig,Anna Berglind,André Berton,Jeannette Bigler,Michael Boedigheimer,Klaus Bønnelykke,Paul Brinkman,Andrew Bush,Davide Campagna,Carmen Casaulta,Amphun Chaiboonchoe,Trevor Davison,Bertrand De Meulder,Ingrid Delin,Patrick Dennison,Paul Dodson,L. El Hadjam,D. Erzen,C. Faulenbach,K. Fichtner,Neil Fitch,Elena Formaggio,Martina Gahlemann,Gabriella Gálffy,D. Garissi,Teresa Garret,E. Guillmant-Farry,Elisabeth Henriksson,Uruj Hoda,JM Hohlfeld,X. Hu,Anna James,Kjetil Breivik Johnson,Nathalie Jullian,Gina Kerry,Matthias Klüglich,Richard G. Knowles,Jon R Konradsen,Kosmas Kretsos,L. Krueger,Ann-Sofie Lantz,Christopher Larminie,Philipp Latzin,Diane Lefaudeux,Nicolas Lemonnier,Lindsay A Lowe,René Lutter,Adina Manta,Alexander Mazein,L. McEvoy,Andrew Menzies-Gow,Nadia Mores,Catherine S. Murray,K Nething,Ulf Nihlén,R M Niven,Bjoern Nordlund,Saul Hannington Nsubuga,Johann Pellet,Carlos Pisón,G. Praticò,M. Puig Valls,Klaus Riemann,J.P. Rocha,Christos Rossios,Giuseppe Santini,Mária Sági,S Scott,Nitin Sehgal,A. Selby,P. O. Söderman,A.O. Sogbesan,Franziska Spycher,Schroder Stephan,Jakob Stokholm,Meera Sunther,Marton Szentkereszty,Lilla Tamási,Kamran Tariq,S. Valente,W.M.C. van Aalderen,C. M. van Drunen,Jonathan van Eyll,Akshay Vyas,W. Zetterguist,Z Zolkipli,Aeilko H. Zwinderman,Alexandre Escolà Agustí,J. Wedzicha,Robab Breyer-Kohansal,Anke-Hilse Maitland-van der Zee,Erik Melén,James P. Allinson,Lowie E.G.W. Vanfleteren,J Vestbo,Ian M. Adcock,Lies Lahousse,Maarten van den Berge,Paul Alter,F. Barbé,Marie-Kathrin Breyer,Otto C. Burghuber,Miquel Teixido Casas,Kian Fan Chung,Borja G. Cosío,Fatima Crispi,Jordi de Batlle,J. Fitting,J Frankenberg Garcia,Jenny Hallberg,Sylvia Hartl,Dave West Hartford Jarvis,A. Mathioudakis,L. Nicod,Alberto Papi,Ann Ritchie,Torben Sigsgaard,Peter J. Sterk,Anja Ullman,Kilian Vellvé,C. Vogelmeier,A. Wheelock,Craig E. Wheelock +170 more
TL;DR: In this article , a post-bronchodilator FEV1/forced vital capacity (FVC) of less than the lower limit of normal at recruitment was defined in a subset of patients with asthma.